论文信息 - COVID-19–Related Thrombotic and Bleeding Events in Adults With Congenital Heart Disease - 字舞流文

COVID-19–Related Thrombotic and Bleeding Events in Adults With Congenital Heart Disease

R. Krasuski | E. Martínez-Quintana | C. Broberg | P. Porayette | S. Klewer | G. Giannakoulas | Jodi L. Feinberg | J. Bouchardy | B. Frischhertz | M. Ladouceur | G. Ephrem | L. Alshawabkeh | Timothy B. Cotts | F. Fusco | G. Scognamiglio | S. Gendi | J. Cramer | D. Tobler | R. García-Orta | F. J. Ruperti-Repilado | Rose Tompkins | Matthew R. Carazo | Soraya Sadeghi | J. Nicolarsen | P. Merás | Kristi Ryan | Javier Ganame | J. Grewal | P. Dehghani | Ian Lindsay | Jamil A. Aboulhosn | George K. Lui | A. Kovacs | Shailendra Upadhyay | Stephen Cook | Scott Cohen | J. J. Araujo | Arvind K. Hoskoppal | Markus Schwerzmann | Anisa Chaudhry | A. Frogoudaki | B. Sarubbi | F. A. Galilea | Sébastien Hascoet | Elizabeth Yeung | Anitha S John | Marlon S. Rosenbaum | Matthew J. Lewis | Fred H Rodriguez | Dan G Halpern | Fernando Baraona | A. M. Cedars | Jong M. Ko | Jennifer R. Maldonado | Amiram Nir | Arsha Karbassi | Benjamin Hendrickson | C. P. Rodriguez-Monserrate | Christopher R. Broda | David Gregg | Eric V. Krieger | Harsimran S. Singh | Almeneisi Hasan | Heather L. Bartlett | Khalid Al Najashi | Lauren Andrade | Matthias Greutmann | Paolo Ferrero | Poyee P. Tung | Stacy D. Fisher

[1] B. Sarubbi,et al. Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study. , 2023, Cardiology in the young.

[2] D. Kell,et al. Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness. , 2022, Seminars in thrombosis and hemostasis.

[3] C. Samama,et al. ISTH guidelines for antithrombotic treatment in COVID‐19 , 2022, Journal of Thrombosis and Haemostasis.

[4] K. Verhamme,et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study , 2022, The Lancet Infectious Diseases.

[5] S. Gharbia,et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[6] B. McCrindle,et al. Coagulation and anticoagulation in Fontan patients. , 2022, The Canadian journal of cardiology.

[7] R. Becker,et al. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium , 2022, Nature Reviews Cardiology.

[8] C. Riou,et al. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose , 2022, The Lancet.

[9] M. Makris,et al. Vaccine-induced immune thrombotic thrombocytopenia , 2021, The Lancet Haematology.

[10] B. Sarubbi,et al. COVID-19 vaccination in adults with congenital heart disease: Real-world data from an Italian tertiary centre , 2021, International Journal of Cardiology Congenital Heart Disease.

[11] E. Holmes,et al. After the pandemic: perspectives on the future trajectory of COVID-19 , 2021, Nature.

[12] S. Middeldorp,et al. COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year , 2021, The Lancet Haematology.

[13] M. Schwerzmann,et al. COVID-19 in Adults With Congenital Heart Disease , 2021, Journal of the American College of Cardiology.

[14] H. Schünemann,et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 , 2021, Blood Advances.

[15] J. Pell,et al. Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients , 2021, Mayo Clinic Proceedings.

[16] J. Hochman,et al. C-reactive protein and clinical outcomes in patients with COVID-19 , 2021, European heart journal.

[17] E. de Jonge,et al. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave , 2020, Thrombosis Research.

[18] J. Hirsch,et al. Gastrointestinal bleeding in hospitalized COVID‐19 patients: a propensity score matched cohort study , 2020, Journal of internal medicine.

[19] Shuo Yan,et al. High prevalence of occult thrombosis in cases of mild/moderate COVID-19 , 2020, International Journal of Infectious Diseases.

[20] B. Clary,et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis , 2020, EClinicalMedicine.

[21] D. Leaf,et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection , 2020, Blood.

[22] Yutao Guo,et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.

[23] G. Lippi,et al. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis , 2020, Thrombosis and Haemostasis.

[24] Mario Plebani,et al. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis , 2020, Clinica Chimica Acta.

[25] M. Schwerzmann,et al. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. , 2020, International journal of cardiology.

[26] Stephanie Fuller,et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[27] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[28] J. Brophy,et al. Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors. , 2015, Circulation.

[29] A. Marelli,et al. Atrial Arrhythmias in Adults With Congenital Heart Disease , 2009, Circulation.

[30] A. Lopes,et al. Long-term Behavior of Endothelial and Coagulation Markers in Eisenmenger Syndrome , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[31] M. Rubens,et al. Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger’s syndrome: a clinical dilemma , 2004, Heart.